Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Nov 8, 2026; 7(3): 125015
Published online Nov 8, 2026. doi: 10.35712/aig.125015
Published online Nov 8, 2026. doi: 10.35712/aig.125015
Table 2 Predictive values at varying pathological complete response prevalence levels
| pCR prevalence (%) | NPV (95%CI) (%) | PPV (95%CI) (%) |
| 15 | 95 (92-97) | 42 (38-46) |
| 18.8 (Validationcohort median) | 94.9 (92-97) | 54.4 (51-56) |
| 22 (Fullcohort median) | 93.7 (92-95) | 59.7 (56-62) |
| 27 | 90 (86-93) | 59 (56-62) |
| 30 | 88 (84-92) | 63 (59-67) |
- Citation: Omullo FP, Kitheghe TK, Sheikh IA, Gakuya AM, Gitumu JM, Shiekh MA, Agai WO, Orenge WB, Gogo HM. Predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer via artificial intelligence: A systematic review and meta-analysis. Artif Intell Gastroenterol 2026; 7(3): 125015
- URL: https://www.wjgnet.com/2644-3236/full/v7/i3/125015.htm
- DOI: https://dx.doi.org/10.35712/aig.125015